4/8
04:02 pm
smmt
Summit Therapeutics (SMMT) is now covered by Citigroup Inc.. They set a "buy" rating on the stock.
Low
Report
Summit Therapeutics (SMMT) is now covered by Citigroup Inc.. They set a "buy" rating on the stock.
4/8
08:03 am
smmt
Summit Therapeutics (SMMT) is now covered by Stifel Nicolaus. They set a "buy" rating and a $45.00 price target on the stock.
Medium
Report
Summit Therapeutics (SMMT) is now covered by Stifel Nicolaus. They set a "buy" rating and a $45.00 price target on the stock.
3/28
08:08 pm
smmt
A Look At Summit Therapeutics (SMMT) Valuation After New Ivonescimab Phase III Data And FDA BLA Filing [Yahoo! Finance]
Medium
Report
A Look At Summit Therapeutics (SMMT) Valuation After New Ivonescimab Phase III Data And FDA BLA Filing [Yahoo! Finance]
3/28
01:29 am
smmt
Summit Therapeutics (SMMT) Is Up 6.9% After Phase III Ivonescimab Data And FDA Filing - What's Changed [Yahoo! Finance]
Medium
Report
Summit Therapeutics (SMMT) Is Up 6.9% After Phase III Ivonescimab Data And FDA Filing - What's Changed [Yahoo! Finance]
3/27
08:15 am
smmt
Multiple Ivonescimab Data Sets from Phase III Studies in Advanced NSCLC Patient Populations to be Featured at ELCC 2026
Medium
Report
Multiple Ivonescimab Data Sets from Phase III Studies in Advanced NSCLC Patient Populations to be Featured at ELCC 2026
3/27
12:22 am
smmt
Akeso Reports Full-Year 2025 Financial Results [Yahoo! Finance]
Low
Report
Akeso Reports Full-Year 2025 Financial Results [Yahoo! Finance]
3/26
05:49 am
smmt
Summit Therapeutics (SMMT) was upgraded by Truist Financial Corporation to "strong-buy".
Low
Report
Summit Therapeutics (SMMT) was upgraded by Truist Financial Corporation to "strong-buy".
3/25
09:38 pm
smmt
Summit Therapeutics (SMMT) Climbs 15.4% Ahead of Pipeline Q2 Updates [Yahoo! Finance]
Medium
Report
Summit Therapeutics (SMMT) Climbs 15.4% Ahead of Pipeline Q2 Updates [Yahoo! Finance]
3/25
05:48 pm
smmt
Prediction: 2 Stocks That Will Be Worth More Than Summit Therapeutics 1 Year From Now [Yahoo! Finance]
Low
Report
Prediction: 2 Stocks That Will Be Worth More Than Summit Therapeutics 1 Year From Now [Yahoo! Finance]
3/16
08:43 am
smmt
Summit Therapeutics (SMMT) was downgraded by Jefferies Financial Group Inc. from "buy" to "hold". They now have a $15.00 price target on the stock.
Low
Report
Summit Therapeutics (SMMT) was downgraded by Jefferies Financial Group Inc. from "buy" to "hold". They now have a $15.00 price target on the stock.
3/11
04:26 pm
smmt
Summit Therapeutics Inc. (SMMT) Presents at The Citizens Life Sciences Conference 2026 Transcript [Seeking Alpha]
Medium
Report
Summit Therapeutics Inc. (SMMT) Presents at The Citizens Life Sciences Conference 2026 Transcript [Seeking Alpha]
3/7
05:30 am
smmt
Summit Therapeutics (SMMT) was upgraded by Zacks Research from "strong sell" to "hold".
Medium
Report
Summit Therapeutics (SMMT) was upgraded by Zacks Research from "strong sell" to "hold".
3/3
02:33 am
smmt
Summit Therapeutics (SMMT) Ends 2025 With Strong Cash Reserves and Increased Clinical Investment [Yahoo! Finance]
Medium
Report
Summit Therapeutics (SMMT) Ends 2025 With Strong Cash Reserves and Increased Clinical Investment [Yahoo! Finance]
3/2
05:00 pm
smmt
Summit Therapeutics Inc. (SMMT) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]
Medium
Report
Summit Therapeutics Inc. (SMMT) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]
3/2
09:46 am
smmt
Summit Therapeutics Inc. (SMMT) Focused on Non-Small Cell Lung Cancer Trial of Ivonescimab [Yahoo! Finance]
Low
Report
Summit Therapeutics Inc. (SMMT) Focused on Non-Small Cell Lung Cancer Trial of Ivonescimab [Yahoo! Finance]
2/26
06:45 pm
smmt
Summit Therapeutics to Present at Upcoming Investor Conferences
Medium
Report
Summit Therapeutics to Present at Upcoming Investor Conferences
2/24
08:24 pm
smmt
Summit Therapeutics Inc (SMMT) Q4 2025 Earnings Call Highlights: Strong Cash Position and ... [Yahoo! Finance]
Low
Report
Summit Therapeutics Inc (SMMT) Q4 2025 Earnings Call Highlights: Strong Cash Position and ... [Yahoo! Finance]
2/24
12:51 pm
smmt
Summit Therapeutics Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Low
Report
Summit Therapeutics Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
2/24
08:02 am
smmt
Summit Therapeutics (NASDAQ:SMMT) had its price target lowered by analysts at HC Wainwright from $40.00 to $30.00. They now have a "buy" rating on the stock.
Low
Report
Summit Therapeutics (NASDAQ:SMMT) had its price target lowered by analysts at HC Wainwright from $40.00 to $30.00. They now have a "buy" rating on the stock.
2/24
07:01 am
smmt
Summit Therapeutics (NASDAQ:SMMT) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Summit Therapeutics (NASDAQ:SMMT) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
2/24
04:22 am
smmt
Summit Therapeutics Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
Summit Therapeutics Q4 Earnings Call Highlights [Yahoo! Finance]
2/24
04:00 am
smmt
Summit Therapeutics Inc. (SMMT) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
Summit Therapeutics Inc. (SMMT) Q4 2025 Earnings Call Transcript [Seeking Alpha]
2/23
04:48 pm
smmt
Summit Therapeutics Non-GAAP EPS of -$0.14 misses by $0.12 [Seeking Alpha]
Low
Report
Summit Therapeutics Non-GAAP EPS of -$0.14 misses by $0.12 [Seeking Alpha]
2/23
04:05 pm
smmt
Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2025
Low
Report
Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2025
2/17
05:30 pm
smmt
Summit Therapeutics to Host Fourth Quarter and Full Year 2025 Financial Results & Operational Progress Call on February 23, 2026 [Yahoo! Finance]
Low
Report
Summit Therapeutics to Host Fourth Quarter and Full Year 2025 Financial Results & Operational Progress Call on February 23, 2026 [Yahoo! Finance]